Therapeutic Targeting of RAS Mutant Cancers(Elements in Molecular Oncology)

RAS突变癌的治疗性靶向

肿瘤学

售   价:
169.00
发货周期:国外库房发货,通常付款后4-6周到货!
作      者
出  版 社
出版时间
2022年09月01日
装      帧
平装
ISBN
9781009073646
复制
页      码
75
开      本
229x152mm
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 30 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
The KRAS oncogene is believed to be the most common single nucleotide variant oncogene in human cancer. Historically, efforts to target KRAS and the other RAS GTPases have struggled. More recently, efforts have focused on identifying and exploiting features unique to specific oncogenic mutations. This has led to the first FDA approval for a RAS targeted therapy. This new agent is a covalent inhibitor that reacts with the cysteine residue created by a codon 12 glycine to cysteine (G12C) mutation within KRAS. Mutant-specific strategies may also exist for other KRAS single nucleotide variants, and recent studies provide examples and mechanisms.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个